This discussion clarifies the typo in Crinetics Pharmaceuticals' 2026 GAAP operating expense guidance, correcting an unrealistic figure to a credible $606 million range.
Generated by Dafinchi AI. Source-grounded AI analysis, not investment advice.
Please clarify the numeric GAAP operating expense guidance for 2026 (prepared remarks contained an apparent typo).
The numeric GAAP operating expense guidance for Crinetics Pharmaceuticals, Inc. for the year 2026 as stated in the earnings transcript contains a clear typo. The prepared remarks indicate the expected GAAP operating expenses for 2026 to be "$606,150,000,000", which is an unrealistic figure given the company's prior expense levels and industry context.
In reality, considering their 2025 operating plans and scale of operations, this number appears to have an extra three zeros. The logically intended figure should be in the range of $606 million rather than $606 billion.
Supporting this correction:
Conclusion:
The correct GAAP operating expense guidance for 2026 is approximately $606.15 million, not $606.15 billion. The typo in the transcript appears to be an extra inclusion of three zeros, and the intended guidance likely reflects an increase from 2025 levels driven by expanded clinical and commercial activities12.
Summary Table
| Metric | Guidance for 2026 | Notes |
|---|---|---|
| GAAP Operating Expenses | ~$606,150,000 (approx.) | Typo in transcript shows extra zeros |
| Non-GAAP Operating Expenses | $480 million – $520 million | Excludes cost of revenue, stock comp, D&A |
| 2025 Cash Usage | $326 million | Provides scale reference |
| 2026 Cash & Investments | ~$1.4 billion (post raise) | Sufficient runway into 2030 |
12
This corrected figure positions Crinetics Pharmaceuticals’ 2026 operating expense guidance in a credible range consistent with their financial scale and growth plans.
Disclaimer: The output generated by dafinchi.ai, a Large Language Model (LLM), may contain inaccuracies or "hallucinations." Users should independently verify the accuracy of any mathematical calculations, numerical data, and associated units, as well as the credibility of any sources cited. The developers and providers of dafinchi.ai cannot be held liable for any inaccuracies or decisions made based on the LLM's output.
PepsiCo said its typical 6–12-month hedging program had buffered some input-cost increases, but costs are rising as those hedges roll off, with effects expected in Q4. Management cited inflation, unfavorable mix, and higher input costs as pressures on margins and earnings guidance, while pointing to pricing and revenue-management actions, productivity, and structural cost reductions as partial offsets.
Sources used
Research questionWhat did management say about Commodity Inflation and Hedge Roll-Off?
Answer outline
NIKE reported 2% North America revenue growth, supported by Performance, but did not disclose U.S.-only scale for Performance, Sportswear, or Jordan. Management called its FY2027 guidance pressure-tested and said it was very confident in the range, while acknowledging significant revenue headwinds and ongoing plan refinement. Available companywide margin figures do not establish the drivers of North America’s EBIT inflection.
Sources used
Research questionHow large are Performance, Sportswear, and Jordan in the U.S., and how do those business trends reconcile with North America revenue growth and a positive regional EBIT margin inflection? How confident is management in its guidance after its initial review of the company?
Answer outline
Management attributes Q2 IMF flow-through drag to triggers from outperforming properties, with stabilization expected after the quarter. They also highlight Marriott-related cost initiatives and efficiency measures that could offset the IMF drag in the second half.
Sources used
Research questionWhat did management say about Marriott IMF flow-through impact?
Answer outline
Host Hotels & Resorts reports that Q2 2026 EBITDA benefited from RevPAR growth but was offset by IMF-driven costs and higher travel-agent commissions, with expectations that these timing effects ease in the second half. Marriott’s ITR-related cost measures provide net support to EBITDA, aligning with the updated guidance and ongoing capital programs.
Sources used
Research questionWhat is the impact of the RevPAR flow-through and Marriott's ITR incentive program on your portfolio's EBITDA and guidance?
Answer outline
Grainger's Q2 2026 margins rose as tariff refunds provided a tailwind, but were offset by mix and freight/private-label headwinds. Management raised the full-year guidance to 15.8%–16.2% while signaling a Q3 margin step-down as tariff benefits lap, with September pricing actions planned to offset ongoing cost pressures.
Sources used
Research questionWhat were the specific drivers behind the Q2 gross margin and operating margin changes (including IEEPA tariff refunds, mix, freight, and private label cost headwinds), and how did management reconcile those to the guidance range?
Answer outline
Sprouts reports mixed results from affordability actions, with assortment-led initiatives showing the strongest momentum and price/promotion delivering limited traffic gains. Management emphasizes reallocating investment to the most responsive items rather than pursuing broad price reductions, citing macro and fuel pressures. The outlook calls for sequential traffic improvement in the second half of 2026, with margins more affected by fuel and fixed-cost deleverage than pricing shifts, and loyalty programs contributing modestly in Q4.
Sources used
Research questionExplain how affordability actions have performed and clarify whether the adjustments imply intensified pricing or changes in spend allocation and the expected impact on the outlook?
Answer outline
CoStar explains how it funds AI initiatives while pursuing its 2030 EBITDA targets, emphasizing disciplined cost management, token-cost optimization, and broader AI-driven productivity gains. Management notes they’re below 2026 token budgets, expect optimization engines to trim costs, and point to labor savings from AI applications as a key margin driver, including a roughly $100 million reduction to the 2026 expense base, supporting the EBITDA trajectory.
Sources used
Research questionI guess maybe on AI initiatives. Can you talk about how you're balancing AI investments as you target kind of your midterm EBITDA 2030 EBITDA targets? And as you deploy this out to more users, I mean, are token costs something we should be thinking about as you try to drive more and more engagement and maintain this kind of AI platform you deployed?
Answer outline
Ecolab's Q2 2026 commentary centers on managing margins amid high-single-digit commodity costs, highlighting a dynamic approach that updates cost assumptions with the latest information rather than sticking to March projections. Management signals a strategy to accelerate energy surcharges and target 5-6% pricing in the second half, aiming to protect profitability and EPS despite ongoing cost pressures and a modest margin drag from Ovivo.
Sources used
Research questionWhat did management say about Commodity price assumptions and margins?
Answer outline
Nike outlines a margin expansion plan anchored in gross margin stabilization, discount discipline in North America, and a structural cost-reduction program across the supply chain. Management also signals near-term revenue moderation alongside an earlier gross margin inflection, aided by tighter buys, lower sell-in, inventory discipline, and more selective promotions, with expectations of returns to double-digit margins in fiscal 2027.
Sources used
Research questionWhat did management say about Margin expansion drivers and cost actions?
Answer outline
Smucker outlines a component-based guidance framework that offsets coffee-driven deflation with modest non-coffee inflation, while signaling offsets via procurement, hedging, productivity, and pricing to stay within guidance.
Sources used
Research questionHow does SJM reconcile the full-year deflation assumption (mid single digit) and low single digit non-coffee cost inflation with the company’s guidance range, especially if geopolitical-driven cost pressures persist?
Answer outline
Ball Corporation's Q1 2026 results showcase robust operational gains and disciplined cost management, setting a positive tone for the year.
Sources used
Research questionWhat are Ball Corporation's updated guidance and outlook for Q1 2026 operational performance and cost management?
Answer outline
Mohawk Industries outlines a comprehensive inflation offset strategy for 2026, emphasizing price increases, product mix improvements, and cost discipline to sustain margins amid persistent inflationary pressures.
Sources used
Research questionWhat is Mohawk Industries' pricing strategy and how does it plan to offset inflation in 2026?
Answer outline
Dafinchi